BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
+23.65%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$138M
AUM Growth
+$138M
(-8.3%)
Cap. Flow
-$18.7M
Cap. Flow
% of AUM
-13.61%
Top 10 Holdings %
Top 10 Hldgs %
79.11%
Holding
58
New
8
Increased
6
Reduced
5
Closed
6
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$47M |
| 2 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
$2.11M |
| 3 |
CFRX
ContraFect Corporation
CFRX
|
$1.61M |
| 4 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$989K |
| 5 |
Soleno Therapeutics
SLNO
|
$794K |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$69.5M |
| 2 |
EQM
EQM Midstream Partners, LP
EQM
|
$1.5M |
| 3 |
DOVA
Dova Pharmaceuticals, Inc. Common Stock
DOVA
|
$1.4M |
| 4 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$660K |
| 5 |
DERM
Dermira, Inc.
DERM
|
$607K |
Sector Composition
| 1 | Healthcare | 94.64% |
| 2 | Energy | 1.7% |
| 3 | Consumer Staples | 0.09% |
| 4 | Materials | 0.06% |
| 5 | Consumer Discretionary | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Workhorse Group
WKHS
$20.3M
| $76K | 0.06% |
25,000
| – | – |
|
52
BioCryst Pharmaceuticals
BCRX
$1.74B
| $69K | 0.05% |
20,000
| – | – |
|
53
Cytokinetics
CYTK
$4.23B
| – | – |
-10,000
| Closed | -$114K |
|
|
MREO
54
Mereo BioPharma
MREO
$272M
| – | – |
-77,570
| Closed | -$231K |
|
55
XBiotech
XBIT
$96.3M
| – | – |
-30,000
| Closed | -$314K |
|
|
GNMX
56
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| – | – |
-128,000
| Closed | -$19K |
|
|
DOVA
57
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| – | – |
-50,000
| Closed | -$1.4M |
|
|
CELG
58
DELISTED
Celgene Corp
CELG
| – | – |
-699,648
| Closed | -$69.5M |
|